financetom
Business
financetom
/
Business
/
Newsletter | Israel-Palestine conflict could mean an uncertain future for tech: Sridhar Vembu; World Mental Health Day & more 
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Newsletter | Israel-Palestine conflict could mean an uncertain future for tech: Sridhar Vembu; World Mental Health Day & more 
Oct 10, 2023 3:05 AM

Here's a rundown of 11 significant news stories to keep you in the know:

Share Market Live

NSE

#LatestNews⚡

Israel Hamas war LIVE Updates: Over 1,500 dead in Israel and Gaza, US reaffirms support to free hostages

Over 900 have been reported dead in Israel and 687 in Gaza, taking the toll to 1,587. Meanwhile, Hamas reportedly claimed to fight Israeli forces in parts of the West Bank on Tuesday. Several foreign nationals are among those killed and held hostage. As the toll continues to mount, Israeli Prime Minister Benjamin Netanyahu vowed on Monday to "change the Middle East" as the army pounded the Gaza Strip with airstrikes.

"What Hamas will experience will be difficult and terrible," he said. Meanwhile, Hamas, which took 150 hostages in its surprise weekend assault on southern Israel, threatened to kill them if Israeli air strikes continue targeting Gaza residents without warning, news agency AFP reported.

Hamas doesn't represent the 'legitimate aspirations' of Palestinians, say US, UK and allies on Israel war

US defence stocks jump while Israel-linked stocks fall globally

Stock traders sent defence companies surging in US markets as an attack on Israel from the Gaza-based militant group Hamas renewed Wall Street’s focus on the security industry.

Shares of arms makers — including Northrop Gruman Corp, L3Harris Technologies Inc., Huntington Ingalls Industries Inc., Lockheed Martin Corp. and General Dynamics Corp. — led gains in the S&P 500 Index on Monday. The stocks each gained at least 8% in the session, the most in more than three years.

The assault on Israel is sparking fresh concern about geopolitical risk among investors who’ve already been grappling with the impact of elevated interest rates and signs of trouble in China’s economy.

#TechTalks

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Satellite Stock AST SpaceMobile Monday?
What's Going On With Satellite Stock AST SpaceMobile Monday?
Jul 1, 2024
AST SpaceMobile, Inc ( ASTS ) stock is trading higher Monday after Chairman and CEO Abel Avellan published a letter to partners, shareholders, and future space-based cellular broadband network users.  Avellan said the strategic partnership with Verizon Communications Inc ( VZ ) , building on its existing agreement with AT&T Inc ( T ) , aims to eliminate connectivity gaps...
Inseego Signs Debt Reduction and Restructuring Agreements; Shares Rise
Inseego Signs Debt Reduction and Restructuring Agreements; Shares Rise
Jul 1, 2024
10:46 AM EDT, 07/01/2024 (MT Newswires) -- Inseego ( INSG ) said Monday it signed a series of agreements to manage its capital structure by reducing total debt and restructuring its outstanding 3.25% convertible notes due 2025. The company's three largest noteholders, representing over $125 million of the outstanding 2025 notes, agreed to sell or exchange their holdings for cash,...
Trading app Robinhood says working to resolve interruption in service
Trading app Robinhood says working to resolve interruption in service
Jul 1, 2024
July 1 (Reuters) - Robinhood said on Monday it was working to resolve an issue that was causing an interruption of service for some users on its trading platform. ...
Longboard Pharmaceuticals Gets FDA Breakthrough Therapy Designation for Seizure Treatment
Longboard Pharmaceuticals Gets FDA Breakthrough Therapy Designation for Seizure Treatment
Jul 1, 2024
10:46 AM EDT, 07/01/2024 (MT Newswires) -- Longboard Pharmaceuticals ( LBPH ) said Monday the US Food and Drug Administration granted breakthrough therapy designation to its investigational drug bexicaserin to treat seizures associated with developmental and epileptic encephalopathies for patients two years and older. The FDA will work closely with us to provide guidance on subsequent development of bexicaserin to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved